Updates on treatment algorithms in metastatic CRC in 2017 - NCCN guidelines

Biomarker Driven Treatment of Metastatic Colorectal Cancer

Dr. Atreya on How the NCCN Guidelines Have Impacted Treatment Options in mCRC

Debate: Is there an optimal sequence for first-line therapy in mCRC? - Yes

Controversy Debate 4: Treatment algorithms in metastatic CRC - NCCN guidelines

ASCO 2023 Expert Report on novelties in the treatment of colorectal cancer by S. Stintzing

The Optimal Dosing Strategy for Regorafenib in mCRC

Updates Rectal Cancer | 2023 Best of GI Cancer Conference

Debate 1: First-line Treatment of Metastatic Colorectal Cancer - CALGB 80405

ESMO Asia mCRC Guidelines: Insights on Impact and Uptake

Guardant Health - Liquid Biopsy Helps Guide mCRC Treatment

Controversy Debate 4: Treatment algorithms in metastatic CRC - ESMO guidelines

Updates on treatment algorithms in metastatic CRC in 2017 - Asian guidelines

Emerging Treatment Options for mCRC Patients in the Late-line Setting

Controversy Debate 4: Treatment algorithms in metastatic CRC - Asian guidelines

Initial Management of Metastatic CRC in 2019

From Bench to Bedside: Evolving targeted treatment landscape in mCRC - guideline and beyond

Emerging Approaches in First-line Therapy for Metastatic Colorectal Cancer

mCRC: Optimising patient outcomes with late-line treatment

Metastatic Colorectal Cancer: Optimizing Dosing Strategy for Late-Line Therapies